Cue Health awarded $28m BARDA contract for multiplex test for Flu, RSV, and COVID-19
Healthcare technology company Cue Health (Nasdaq: HLTH) announced that it has been awarded a contract worth approximately $28 million by the Biomedical Advanced Research and ... Read More
Microbiome company Vedanta Biosciences raises $68m in Series D
Vedanta Biosciences, a clinical-stage microbiome company founded by PureTech Health, has raised $68 million in a Series D financing round led by affiliates of Magnetar ... Read More
Cipla Therapeutics partners with SIGA Technologies for antibacterial drugs
Cipla Therapeutics, an Indian pharma company, and SIGA Technologies have entered into a partnership to provide sustained innovation and access to novel antibacterial drugs, especially ... Read More
Moderna bags $1.5bn contract to supply mRNA-1273 Covid-19 vaccine to US govt
Moderna has bagged a deal worth up to $1.52 billion for the manufacturing and supply of 100 million doses of its mRNA-1273 vaccine candidate for ... Read More